1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: August 30 - September 5, 2026
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: August 30 - September 5, 2026

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Kyle Diamantas, J.D., Acting Commissioner of Food and Drugs

Event Date: 08/31/2026
Location: Washington, DC
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Paul Atkins (U.S. Securities and Exchange Commission);

Official Name: Sean R. Keveney, J.D., Chief Counsel

No Significant Event

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 08/31/2026
Location: Virtual 
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Steve Goldstein (University of New Mexico);

Event Date: 09/03/2026
Location: Washington, DC
Subject: Association of Clinical Research Organizations (ACRO) Third Quarter Board Meeting; Speaker: Operation Trialblazer 
FDA Participant/Group: N/A
Non FDA Participant/Group: Association of Clinical Research Organizations (ACRO) board members

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives

Event Date: 09/01/2026
Location: Silver Spring, MD
Subject: Introductory Meeting
FDA Participant/Group: BRIAN FAHEY; LUKE HALL; AMY RICK; 
Non FDA Participant/Group: Andrew Slugg, Debi Tran, Deidre Parsons (Alnylam); John Martin (Capital Counsel);

Event Date: 09/02/2026
Location: Washington, DC
Subject: Regulatory AI Forum 2026; Speaker: Fireside Chat - AI/Data Infrastructure at the Industry/Agency Interface
FDA Participant/Group: LUKE HALL; 
Non FDA Participant/Group: Life sciences, government, technology development, and other registered attendees

Event Date: 09/04/2026
Location: Virtual
Subject: Regulatory Issues
FDA Participant/Group: LUKE HALL; BRIAN FAHEY; 
Non FDA Participant/Group: Azim Chowdhury (Keller and Heckman LLP); Steven Haddad, Tiffany Shaba (Capital Sales Company); Rachael Schmidt (ALINC Consulting LLC);

Official Name: Donald A. Prater, D.V.M., Acting Deputy Commissioner for Food

Event Date: 08/31/2026
Location: Baltimore, MD
Subject: Olive Oil Issues of Mutual Interest
FDA Participant/Group: GREGORY NOONAN; YINQING MA; ELIZABETH MILLER; CLAUDINE KAVANAUGH; PIERLUIGI DELMONTE; 
Non FDA Participant/Group: Pompeian, Inc., North American Olive Oil Association, and the Akin Group representatives

Event Date: 09/03/2026
Location: College Park, MD
Subject: Food Additive Issues of Mutual Interest
FDA Participant/Group: NINA BITTMAN; MARK HARTMAN; KRISTI MULDOON JACOBS; REBECCA BUCKNER; LARRY MORRIS; 
Non FDA Participant/Group: Plastics Industry Association and Keller and Heckman LLP representatives

Event Date: 09/04/2026
Location: Dulles, VA
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: International Flight Services Association representatives

Official Name: Melanie Keller, M.B.A., Deputy Commissioner for Operations and Chief Operating Officer

No Significant Event

Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations

No Significant Event

Official Name: Karim Mikhail, B.Pharm, MSc, Acting Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

Event Date: 09/02/2026
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: ForHims representatives

Event Date: 09/02/2026
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: N/A
Non FDA Participant/Group: GE representatives

Official Name: Michael Davis, M.D., Ph.D., Acting Director, Center for Drug Evaluation and Research

Event Date: 09/01/2026
Location: Virtual
Subject: Duke Margolis Quantitative Medicine Summit; Speaker: Opening Remarks
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Event Date: 09/02/2026
Location: Silver Spring, MD
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Laila Gurney (GE Healthcare);

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products

Event Date: 09/01/2026
Location: Silver Spring, MD
Subject: Tobacco Regulatory Pathways and Public Education Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Keagan Lenihan, Matt Holman, Stacey Kennedy (Philip Morris International);

Official Name: Timothy C. Schell, Ph.D., Director, Center for Veterinary Medicine

No Significant Event

Back to Top